Amgen Inc. (AMGN) to Issue Quarterly Dividend of $2.52 on September 11th

Amgen Inc. (NASDAQ:AMGN) announced a quarterly dividend on Thursday, July 30th. Investors of record on Friday, August 21st will be given a dividend of 2.52 per share by the medical research company on Friday, September 11th. This represents a c) annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Friday, August 21st.

Amgen has increased its dividend by an average of 0.1%annually over the last three years and has increased its dividend annually for the last 14 consecutive years. Amgen has a payout ratio of 46.8% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Amgen to earn $24.24 per share next year, which means the company should continue to be able to cover its $10.08 annual dividend with an expected future payout ratio of 41.6%.

Amgen Stock Up 1.4%

Shares of AMGN stock opened at $425.28 on Wednesday. The stock has a market cap of $229.92 billion, a P/E ratio of 26.43, a price-to-earnings-growth ratio of 3.86 and a beta of 0.41. Amgen has a one year low of $269.77 and a one year high of $427.39. The stock has a fifty day moving average price of $373.66 and a 200 day moving average price of $360.06. The company has a debt-to-equity ratio of 4.44, a current ratio of 1.37 and a quick ratio of 1.13.

Amgen (NASDAQ:AMGN) last released its quarterly earnings data on Tuesday, August 4th. The medical research company reported $6.29 earnings per share for the quarter, beating analysts’ consensus estimates of $5.62 by $0.67. The company had revenue of $10.05 billion for the quarter, compared to the consensus estimate of $9.43 billion. Amgen had a return on equity of 124.14% and a net margin of 22.95%.The company’s quarterly revenue was up 9.5% on a year-over-year basis. During the same period in the previous year, the business earned $6.02 earnings per share. Amgen has set its FY 2026 guidance at 22.300-23.500 EPS. Analysts predict that Amgen will post 22.78 earnings per share for the current year.

About Amgen

Amgen Inc (NASDAQ: AMGN) is a global biotechnology company founded in 1980 and headquartered in Thousand Oaks, California. The company focuses on discovering, developing, manufacturing and delivering human therapeutics that address serious illnesses. Amgen’s work centers on biologic medicines derived from cellular and molecular biology, with an emphasis on translating advances in human genetics and protein science into therapies for patients.

Amgen’s commercial portfolio has historically included biologics used in oncology, supportive care, nephrology, bone health and cardiovascular disease.